Skip to content

Advertisement

  • Erratum
  • Open Access
  • Open Peer Review

Erratum To: The burden of diarrhoea, shigellosis, and cholera in North Jakarta, Indonesia: findings from 24 months surveillance

  • 1Email author,
  • 1,
  • 2,
  • 2,
  • 2,
  • 1, 2,
  • 2,
  • 3,
  • 1,
  • 4,
  • 1,
  • 5,
  • 5,
  • 6,
  • 6,
  • 6,
  • 6,
  • 6,
  • 6,
  • 6,
  • 1,
  • 1,
  • 2,
  • 2,
  • 2,
  • 2 and
  • 6, 7
BMC Infectious Diseases20077:1

https://doi.org/10.1186/1471-2334-7-1

  • Received: 10 October 2006
  • Accepted: 26 January 2007
  • Published:

The original article was published in BMC Infectious Diseases 2005 5:89

Open Peer Review reports

Abstract

This is a correction of an earlier published article.

Text

After the publication of this work[1], we became aware that the our description of the methods used to identify Shigella spp. did not describe the identification of a subset of Shigella spp. which were untypeable with commercial sera. Additional typing was conducted by Dr. Kaisar A. Talukder and coworkers (Laboratory Sciences Division, ICDDR, B: Centre for Health and Population Research, GPO Box-128, Dhaka-1000, Bangladesh. Email:kaisar@icddrb.org.)

Brief description of the methods used for serotyping the untypeable S. flexneristrains using MASF

All Shigella strains which agglutinated with commercial polyvalent anti-S. flexneri serum (Denka Seiken, Tokyo, Japan) but were untypeable using commercial serotype specific antisera were examined using a panel of monoclonal antibodies against S. flexneri (MASF B) according to the typing scheme shown in Table 1 using monoclonal antibodies from one supplier (Reagensia AB, Stockholm, Sweden) with the exception of MASF 1c which was provided by Dr. N. I. A. Carlin (SBL, Sweden) [25]. Untypeable S. flexneri strains which agglutinated strongly with polyclonal MASF B and type antigen factor IV-2 but not with group factor Y-5 or 6 thereby excluding their characterization into serotype 4a or 4b were designated as serotype 4 if they agglutinated with a new antigenic determinant E1037 (IV-1). Untypeable strains which agglutinated with antibodies against the provisional antigen, MASF IV-1 specific for the new antigenic determinant E1037, were designated as 4X. Untypeable strains which agglutinated only with MASF Ic were designated as 1c.
Table 1

S. flexneri serotyping criteria using MASF antibodies

Serotype

Type antigen specific

MASF B

Group antigen specific

Provisional antigen specific

 

1 (1:-)a

11 (11:-)

IV-2 (IV:-)

V (V:-)

VI (VI:-)

B (-:1)

Y-5 (-:3.4)

6 (-:6)

7.8 (-:7.8)

IV-1 (-:E1037)

1c

1a

+

    

+

+

    

1b

+

    

+

 

+

   

1c

     

+

    

+

2a

 

+

   

+

+

    

2b

 

+

   

+

  

+

  

3a

     

+

 

+

+

  

3b

     

+

+

+

   

3c

     

+

 

+

   

4:-

  

+

  

+

   

+

 

4a

  

+

  

+

+

  

+/-

 

4b

  

+

  

+

 

+

   

5a

   

+

 

+

+

    

5b

   

+

 

+

  

+

  

6

    

+

+

   

+/-

 

X

     

+

  

+

+/-

 

Y

     

+

+

  

+/-

 

4X

     

+

   

+

 

a Shown in parentheses is the antigen recognized.

+ Positive reaction

Notes

Authors’ Affiliations

(1)
National Institute of Health Research and Development, Jakarta Indonesia, Ministry of Health, Jakarta, Indonesia
(2)
United States Navy Medical Research Unit 2, Jakarta, Indonesia
(3)
Infectious Disease Hospital Sulianti Saroso, Ministry of Health, Jakarta, Indonesia
(4)
Communicable Disease Control and Environmental Health, Ministry of Health, Jakarta, Indonesia
(5)
Department of Microbiology, University of Indonesia, Jakarta, Indonesia
(6)
International Vaccine Institute, Seoul, South Korea
(7)
National Institute of Child Health and Human Development, Bethesda, Maryland, USA

References

  1. Agtini MD, Soeharno R, Lesmana M, Punjabi NH, Simanjuntak C, Wangsasaputra F, Nurdin D, Pulungsih SP, Rofiq A, Santoso H, Pujarwoto H, Sjahrurachman A, Sudarmono P, von Seidlein L, Deen JL, Ali M, Lee H, Kim DR, Han O, Park JK, Suwandono A, Ingerani, Oyofo BA, Campbell JR, Beecham HJ, Corwin AL, Clemens JD: The burden of diarrhoea, shigellosis, and cholera in North Jakarta, Indonesia: findings from 24 months surveillance. BMC Infect Dis. 2005, 5: 89-10.1186/1471-2334-5-89.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Carlin NI, Rahman M, Sack DA, Zaman A, Kay B, Lindberg AA: Use of monoclonal antibodies to type Shigella flexneri in Bangladesh. J Clin Microbiol. 1989, 27 (6): 1163-1166.PubMedPubMed CentralGoogle Scholar
  3. Talukder KA, Dutta DK, Safa A, Ansaruzzaman M, Hassan F, Alam K, Islam KM, Carlin NI, Nair GB, Sack DA: Altering trends in the dominance of Shigella flexneri serotypes and emergence of serologically atypical S. flexneri strains in Dhaka, Bangladesh. J Clin Microbiol. 2001, 39 (10): 3757-3759. 10.1128/JCM.39.10.3757-3759.2001.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Talukder KA, Islam MA, Dutta DK, Hassan F, Safa A, Nair GB, Sack DA: Phenotypic and genotypic characterization of serologically atypical strains of Shigella flexneri type 4 isolated in Dhaka, Bangladesh. J Clin Microbiol. 2002, 40 (7): 2490-2497. 10.1128/JCM.40.7.2490-2497.2002.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Talukder KA, Islam Z, Islam MA, Dutta DK, Safa A, Ansaruzzaman M, Faruque AS, Shahed SN, Nair GB, Sack DA: Phenotypic and genotypic characterization of provisional serotype Shigella flexneri 1c and clonal relationships with 1a and 1b strains isolated in Bangladesh. J Clin Microbiol. 2003, 41 (1): 110-117. 10.1128/JCM.41.1.110-117.2003.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/7/1/prepub

Copyright

© Agtini et al; licensee BioMed Central Ltd. 2007

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement